What is the administration instruction for SPIRIVA?

The administration instruction for SPIRIVA involves inhaling one capsule once daily. This medication contains tiotropium, which is a long-acting muscarinic antagonist (LAMA) used primarily for the management of chronic obstructive pulmonary disease (COPD) and asthma. It is designed to be taken once a day due to its extended duration of action, which provides consistent bronchodilation over a 24-hour period.

Inhaling one capsule daily maximizes its effectiveness while minimizing the risk of side effects associated with higher doses or more frequent dosing. This allows patients to maintain good control over their respiratory condition without having to remember to take multiple doses each day. The single daily inhalation ensures that therapeutic levels of the medication are sustained throughout the day, which is crucial for managing symptoms and improving lung function effectively.

Other administration methods, such as injections or additional capsules taken throughout the day, are not indicated for SPIRIVA and could lead to ineffective treatment or increased risk of adverse effects. Thus, the specific guidance of one capsule per day aligns with the therapeutic goals of the medication.